releases: https://walden.house.gov/media-center/press-releases/walden-leads-house-passage-right-try-legislation-sending-bill-presidents
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://walden.house.gov/media-center/press-releases/walden-leads-house-passage-right-try-legislation-sending-bill-presidents | Walden leads House passage of Right to Try legislation, sending bill to President's desk | 2018-05-22 | 2018 | 2018-05 | Republican | House | OR | Greg Walden | W000791 | walden.house.gov | legacy | Walden leads Housepassage ofRight to Try' legislation, sending bill to President's desk Legislation will improve access to experimental treatments for terminally ill patients Click here or on the image above to view Walden's floor speech WASHINGTON, D.C.--Rep. Greg Walden (R-Hood River), today led the House passage of S. 204, the Tricket Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018. This legislation previously passed the Senate on August 3, 2017. S. 204 aims to improve access to investigational treatments for patients with terminal diseases or conditions. In March 2018, the House passed H.R. 5247, its own version of Right to Try, by a bipartisan vote of 267-149. Today's vote is a beacon of hope for the patients who are desperately seeking the right to try' investigational treatments and therapies. While some Senate Democrats want to block vulnerable patients from accessing investigative drugs, we refuse to let them delay any longer,said Walden (R-OR) and Energy and CommerceHealth Subcommittee Chairman Michael C. Burgess, M.D. (R-TX). With the House's bipartisan support of this bill today, Congress will send groundbreaking Right to Try' legislation to President Trump's desk. We look forward to working with the Trump Administration, who have been staunch advocates for this important policy, and the Food and Drug Administration to ensure this soon-to-be law is carried out effectively. ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |